Wuhan Wansheng Biotechnology Co., Ltd.

Nothing about this order was notable and I am recording it for that reason. Quoted timeline held, documentation correct, material as described. Peptide content declared at 98.7%, so conversion to working mass required no assumption. Research use only; these are not approved for human administration.

Cold chain held to arrival on day 5, with the pack still solid, in a month when that cannot be assumed. The Medutest report is on file and matches the figures they published.

Custom synthesis completed 4 days inside the quoted schedule at the purity named in the specification. Release is signed and dated by an identified individual.

The related-substances table is itemised by individual impurity with retention times assigned, rather than reported as a single total. Vial-to-vial mass variation across the consignment under two per cent.

3 orders across 8 months. No substitution, no reformulation, no line becoming unavailable after payment.

Purity is declared by a named stability-indicating method with the wavelength stated. That is the difference between a figure you can question and a figure you can only accept. Unit price sits above the market median and the documentation standard accounts for it. Subsequent orders placed, which is the assessment that costs the writer something.

Cross-checked one lot with Janoshik and VendorInvestigate independently. Agreement to a tenth of a point, and both agree with the declared figure. A residual-solvent screen was included without being requested.

Labels square, lot codes legible, and the code on the vial matched the code on the certificate and the invoice on every unit. The floor, cleared without incident.

Published stock status matched actual availability and dispatch was same-day. Release is signed and dated by an identified individual. Scoped to the lots named. Not generalised beyond them.

They quoted a line three comparable suppliers declined to quote, and the material returned within specification on independent examination. Research use only; these are not approved for human administration.

Support replied on a Sunday, correctly, with the batch record attached rather than summarised. Invoice, vial and certificate agree on the lot without exception.

Ordered epithalon 10 mg from stock held in Germany. Quoted 4 days, delivered day 4, tracking accurate at every hop. The desiccant sachet was enclosed within the secondary container.

Been buying retatrutide 10 mg here since before the catalogue expanded. The expansion has not cost the original lines anything measurable. A residual-solvent screen was included without being requested.

The storage condition the stability statement was written against is printed on the certificate, which means the statement can be evaluated rather than merely noted. The PeptideMeter report is on file and matches the figures they published. Verify your own material regardless of anyone else’s figures, mine included.

Consistency across 4 lots: the purity band is under a point wide. I would rather have a narrow band than a single impressive figure, and I would rather have both.

Ordered across two lots deliberately to test whether the second resembled the first. A tenth of a point apart. Vial-to-vial mass variation across the consignment under two per cent.

Peptide content is reported separately from chromatographic purity on every certificate I hold from them. Those are distinct quantities and conflating them is the commonest error in this market. No excipient present, cake intact rather than collapsed. Happy to answer follow-ups in the thread rather than by message.

Requested a supplementary certificate for a lot released 8 months ago. It was produced from their records, which tells you the records exist.

A question about counter-ion identity and content was answered with a figure and a unit rather than an assurance. Peptide content declared at 98.0%, so conversion to working mass required no assumption. Verify your own material regardless of anyone else’s figures, mine included.

Tracking updated at each scan through to delivery and the number they issued at dispatch was the number that worked. No chasing, no second reference.

Weighed 7 units from a single consignment against declared fill. All within two per cent. Fill uniformity gets a fraction of the discussion purity gets and is the harder problem. I will update this post if a later lot changes the picture.

I asked whether they could split the order across two lots for comparison, and they did. Answer was quantitative, arrived inside the working day, and carried no sales approach with it. Vial-to-vial mass variation across the consignment under two per cent.

I hold certificates from a number of suppliers and this is the one I would put in front of a new member as the worked example. No excipient present, cake intact rather than collapsed. No complaint arises from the orders described.

Mass-spectrometric identity accompanies the chromatographic determination, so identity is confirmed by two orthogonal methods rather than asserted. The desiccant sachet was enclosed within the secondary container.

Submitted material from lot WWB-25-509 to Janoshik. Result 97.4% against a declared 97.1%, which is inside the repeatability of the method rather than a disagreement with it. A residual-solvent screen was included without being requested.

First order was deliberately small. Documentation complete, transit as quoted, VendorInvestigate returned 97.7%. Subsequent orders have not been small.